Overactive Bladder - Results from #1720

Reproducibility of urodynamic filling sensation at weekly interval in healthy volunteers and in women with detrusor overactivity - Abstract May 23, 2011

AUA 2011 - Insight into percutaneous tibial nerve stimulation: Critical evaluation of the SUmiT Trial - Session Highlights May 22, 2011

AUA 2011 - Modifiable lifestyle behaviors and incidence of lower urinary tract symptoms and urine leakage in a population-based study of men and women - Session Highlights May 19, 2011

AUA 2011 - Progression and remission of urologic symptoms: longitudinal results from the Boston area community health (BACH) survey - Session Highlights May 19, 2011

AUA 2011 - What is on the horizon in drug therapy for OAB? - Slide Presentation May 17, 2011

Women's experience with severe overactive bladder symptoms and treatment: Insight revealed from patient focus groups - Abstract May 13, 2011

The afferent system and its role in lower urinary tract dysfunction - Abstract May 12, 2011

Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder - Abstract May 11, 2011

Differential profile analysis of urinary cytokines in patients with overactive bladder - Abstract May 11, 2011

Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target - Abstract May 9, 2011

SUFU 2011 - Is “OAB-dry” really dry? - Session Highlights May 9, 2011

Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome - Abstract May 5, 2011

Update on the treatment of overactive bladder - Abstract May 2, 2011

Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury - Abstract April 29, 2011

Prolonged urinary retention after intravesical botulinum injection for treatment of idiopathic detrusor overactivity - Abstract April 28, 2011

Implantation of artificial urinary sphincter in patients with post-prostatectomy incontinence, and preoperative overactive bladder and mixed symptoms - Abstract April 27, 2011

Botulinum toxin A submucosal injection for refractory non-neurogenic overactive bladder: Early outcomes - Abstract April 25, 2011

Sacral neuromodulation for treating neurogenic bladder dysfunction: Clinical and urodynamic study - Abstract April 22, 2011

Percutaneous radiofrequency sacral rhizotomy in the treatment of neurogenic detrusor overactivity in spinal cord injured patients - Abstract April 21, 2011

NAFC research on overactive bladder and nocturia published April 21, 2011

Page 87 of 89